European Markets Hit Record Peak on Healthcare and Tech Gains

Bayer spearheaded the market momentum, with its share price jumping 18.7% following a favorable legal ruling in the United States. This pharmaceutical boost provided a critical anchor for the index, helping to offset a late-session cooling in the tech sector, which had initially been galvanized by strong earnings forecasts from Micron and Qualcomm.

Broader market sentiment remains tempered by the potential for further interest rate adjustments from the Federal Reserve and the European Central Bank. Investors are balancing optimistic corporate performance against persistent U.S. inflation data and ongoing international tensions, creating a cautious outlook for future sessions.